Publications

Journal Article
Meta-Analysis Research Support, Non-U.S. Gov't
Ppublish 1017 citations
Electronic publication date
August 15, 1993

View on Pubmed.gov 8328741 | View on doi.org 10.7326/0003-48...

Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Search for publications in this journal Ann Intern Med - 119(4):312-23

Abstract

PURPOSE

To determine whether alpha-interferon is effective in terminating viral replication and in eradicating the carrier state in patients with chronic hepatitis B virus (HBV) infection.

DATA SOURCES

Randomized controlled studies published in the English literature between January 1966 and June 1992 were identified through a MEDLINE computer search.

STUDY SELECTION

Fifteen randomized controlled studies with a total of 837 adult chronic HBV carriers who were positive for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) were identified. Studies were included if patients were treated for at least 3 months and followed for at least 6 months after cessation of therapy.

RESULTS

Overall, the loss of HBsAg occurred 6% more often in interferon-treated patients than the natural seroconversion seen in controls (7.8% compared with 1.8%, P = 0.001), and the loss of viral replication occurred approximately 20% more often in treated patients than in controls (33% compared with 12% for loss of HBeAg and 37% compared with 17% for the loss of HBV DNA, P = 0.0001) if patients received interferon for 3 to 6 months and were followed for 6 to 12 months. Interferon also had a significant treatment effect on the development of antibodies to HBsAg (anti-HBs), antibodies to HBeAg (anti-HBe), and on the normalization of alanine aminotransferase levels.

CONCLUSIONS

Alpha-interferon is effective in terminating viral replication and in eradicating the carrier state in patients with chronic HBV infection who are HBeAg positive when these patients are treated for 3 to 6 months and followed for 6 to 12 months after cessation of therapy. Follow-up studies are required to determine whether interferon reduces the risk for developing cirrhosis or hepatocellular carcinoma.

References

No references provided.

Cited by 1017 citations (total)

Journal Article Review

The role of interferon therapy in hepatitis B.

Electronic publication date May 19, 2006

Search for publications in this journal MedGenMed

W Graham E Cooksley

Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Hepatitis B testing among Vietnamese American men.

Electronic publication date November 9, 2004

Search for publications in this journal Cancer Detect Prev

Victoria M Taylor [...] J Carey Jackson et al.

Vietnamese American men are over 10 times more likely to be diagnosed with liver cancer than their white counterparts. This...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances